The JAK 2V 617 F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
暂无分享,去创建一个
R. Kralovics | R. Skoda | E. Lippert | M. Boissinot | F. Girodon | I. Dobo | V. Praloran | N. Boiret-Dupré | S. Hermouet